Major depression and treatment response in adolescents with ADHD and substance use disorder

Drug and Alcohol Dependence

Volumn 120, Issue 1-3, 2012, Pages 214-219

  Warden, Diane ^a   Riggs, Paula D ^b   Min, Sung Joon ^c   Mikulich Gilbertson, Susan K ^b   Tamm, Leanne ^d   Trello Rishel, Kathlene ^a   Winhusen, Theresa ^e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b UNIVERSITY OF COLORADO   (United States)

^c UNIVERSITY OF COLORADO   (United States)

^d CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^e UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Adolescents; Attention deficit hyperactivity disorder; Comorbid disorder; Major depressive disorder; Substance use disorder; Treatment outcomes

Indexed keywords

ALCOHOL; AMPHETAMINE; COCAINE; METHYLPHENIDATE; OPIATE; PLACEBO; PSYCHEDELIC AGENT; SEDATIVE AGENT;

ADOLESCENT; AGE; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COGNITIVE THERAPY; CONTROLLED STUDY; COURT REFERRAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE SEVERITY; DRUG DEPENDENCE TREATMENT; DRUG DOSE TITRATION; DRUG RELEASE; FEMALE; GENDER; HUMAN; LEGAL ASPECT; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; MULTICENTER STUDY; OSMOTIC RELEASE; PATIENT COMPLIANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SUBSTANCE ABUSE; SYMPTOM; TREATMENT RESPONSE; URINALYSIS;

ADOLESCENT; ALCOHOL-RELATED DISORDERS; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CENTRAL NERVOUS SYSTEM STIMULANTS; COGNITIVE THERAPY; COMBINED MODALITY THERAPY; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; MALE; METHYLPHENIDATE; SUBSTANCE-RELATED DISORDERS; TOBACCO USE DISORDER; TREATMENT OUTCOME;

EID: 84155167324     PISSN: 03768716     EISSN: 18790046     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2011.08.001     Document Type: Article

References (48)

1. Baker K.D., Lubman D.I., Cosgrave E.M., Killackey E.J., Yuen H.P., Hides L., Baksheev G.N., Buckby J.A., Yung A.R. Impact of co-occurring substance use on 6 month outcomes for young people seeking mental health treatment. Aust. N. Z. J. Psychiatry 2007, 41:896-902.
2. Bostic J.Q., Biederman J., Spencer T.J., Wilens T.E., Prince J.B., Monuteaux M.C., Sienna M., Polisner D.A., Hatch M. Pemoline treatment of adolescents with attention deficit hyperactivity disorder: a short controlled trial. J. Child Adolesc. Psychopharmacol. 2000, 10:205-216.
3. Brown R.A., Evans M., Miller I.W., Burgess E.S., Mueller T.I. Cognitive-behavioral treatment for depression in alcoholism. J. Consult. Clin. Psychol. 1997, 65:715-726.
4. Buckstein O., Glancy L.J., Kaminer Y. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers. J. Am. Acad. Child Adolesc. 1992, 31:1041-1045.
5. Buckstein O.G., Horner M.S. Management of the adolescent with substance use disorders and comorbid psychopathology. Child Adolesc. Psychiatr. Clin. N. Am. 2010, 19:609-623.
6. Candy B., Jones L., Williams R., Tookman A., King M. Psychostimulants for depression (intervention review). Cochrane Database Syst. Rev. 2008, 2. CD006722. 10.1002/14651858.
7. Carroll K. Behavioral therapies for co-occurring substance use and mood disorders. Biol. Psychiatry 2004, 56:778-784.
8. Chan Y., Dennis M.L., Funk R.R. Prevalence and comorbidity of major internalizing and externalizing problems among adolescents and adults presenting to substance abuse treatment. J. Subst. Abuse Treat. 2008, 34:14-24.
9. Cornelius J.R., Bukstein O.G., Douaihy A.B., Clark D.B., Chung T.A., Daley D.C., Wood D.S., Brown S.J. Double-blind fluoxetine trial in comorbid MDD-CUD youth and young adults. Drug Alcohol Depend. 2010, 112:39-45.
10. Cornelius J.R., Bukstein O.G., Wood D.S., Kirisci L., Douaihy A., Clark D.B. Double-blind placebo-controlled trial of fluoxetine in adolescents with comorbid major depression and an alcohol use disorder. Addict. Behav. 2009, 34:905-909.
11. Costello A.J., Edelbrock C.S., Kalas R., Kessler M.K., Klaric S.A. NIMH Diagnostic Interview Schedule for Children 1982, National Institute of Mental Health, Bethesda, MD.
12. Cottler L.B., Robins L.N., Helzer J.E. The reliability of the CIDI-SAM: a comprehensive substance abuse interview. Br. J. Addict. 1989, 84:801-814.
13. Crowley T., Mikulich S., Ehlers K., Whitmore E., Macdonald M. Validity of structured clinical evaluations in adolescents with conduct and substance problems. J. Am. Acad. Child Adolesc. Psychiatry 2001, 40:265-273.
14. Crowley T.J., Mikulich S.K., MacDonald M., Young S.E., Zerbe G.O. Substance-dependent, conduct-disordered adolescent males: severity of diagnosis predicts 2-year outcome. Drug Alcohol Depend. 1998, 49:225-237.
15. Deas D., Randall C.L., Roberts J.S., Anton R.F. A double-blind, placebo-controlled trial of sertraline in depressed adolescent alcoholics: a pilot study. Hum Psychopharmacol. 2000, 15:461-469.
16. Deykin E.Y., Buka S.L., Zeena T.H. Depressive illness among chemically dependent adolescents. Am. J. Psychiatry 1992, 149:1341-1347.
17. Dobkin P.L., Chabot L., Maliantovitch K., Craig W. Predictors of outcome in drug treatment of adolescent inpatients. Psychol. Rep. 1998, 83:175-186.
18. DuPaul G.J., Power T.J., Anastopoulos A.D., Reid R. ADHD Rating Scale-IV: Checklists, Norms, and Clinical Interpretations 1998, The Guilford Press, New York, NY.
19. Fisher P., Shaffer D., Piacentini J., Lapkin J., Wicks J., Rojas M. Completion of Revisions of the NIMH Diagnostic Interview Schedule for Children (DISC-2) 1991, Epidemiology and Psychopathology Research, National Institute of Mental Health, Washington, DC.
20. Geller D., Biederman J., Faraone S.V., Frazier J., Coffey B.J., Kim G., Bellordre C.A. Clinical correlates of obsessive compulsive disorder in children and adolescents referred to specialized and non-specialized clinical settings. Depress. Anxiety 2000, 11:163-168.
21. Grella C.E., Hser Y., Joshi V., Rounds-Bryant J. Drug treatment outcomes for adolescents with comorbid mental and substance use disorders. J. Nerv. Ment. Dis. 2001, 189:384-392.
22. Kadden R., Carroll K., Donovan D., Cooney N., Monti P., Abrams D., Litt M., Hester R. Cognitive-Behavioral Coping Skills Therapy Manual 1995, vol. 3. National Institute of Alcohol Abuse and Alcoholism, Rockville, MD.
23. Kaminer Y., Tarter R.E., Bukstein O.G., Kabene M. Comparison between treatment completers and noncompleters among dually diagnosed substance-abusing adolescents. J. Am. Acad. Child Adolesc. Psychiatry 1992, 31:1046-1049.
24. Kratochvil C.J., Newcorn J.H., Arnold L.E., Duesenberg D., Emslie G.J., Quintana H., Sarkis E.H., Wagner K.D., Gao H., Michelson D., Biederman J. Atomoxetine alone or combined with fluoxetine for treating ADHD with comorbid depressive or anxiety symptoms. J. Am. Acad. Child Adolesc. Psychiatry 2005, 44:915-924.
25. Ling W., Shoptaw S., Wesson D., Rawson R.A., Compton M., Klett C.J. Treatment effectiveness score as an outcome measure in clinical trials. NIDA Res. Monogr. 1997, 175:208-220.
26. Magura S. Effectiveness of dual focus mutual aid for co-occurring substance use and mental health disorders: a review and synthesis of the double trouble in recovery evaluation. Subst. Use Misuse 2008, 43:1904-1926.
27. Maude-Griffin O.M., Hohenstein J.M., Humfleet G.L., Reilly P.M., Tusel D.J., Hall S.M. Superior efficacy of cognitive-behavioral therapy for crack cocaine abusers: main and matching effects. J. Consult. Clin. Psychol. 1998, 66:832-837.
28. Miller W.R., Del Boca F.K. Measurement of drinking behavior using the Form 90 family of instruments. J. Stud. Alcohol 1994, 12:112-118.
29. Monti P.M., Abrams D.B., Kadden R.M., Cooney N.L. Treating Alcohol Dependence: A Coping Skills Training Guide 1989, Guilford Press, New York, NY.
30. Nunes E.V., Levin F.R. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. J. Am. Med. Assoc. 2004, 291:1887-1896.
31. Orvaschel H., Puig-Antich J. Schedule for Affective Disorders and Schizophrenia for School-Age Children: Epidemiologic, 4th version 1987, Nova University, Center for Psychological Study, Ft. Lauderdale, FL.
32. Prince J.B., Wilens T.E., Biederman J., Spencer T.J., Millstein R., Polisner D.A., Bostic J.Q. A controlled study of nortriptyline in children and adolescents with attention deficit hyperactivity disorder. J. Child Adolesc. Psychopharmacol. 2000, 10:193-204.
33. Rao U., Chen L.A. Neurobiological and psychosocial processes associated with depressive and substance-related disorders in adolescents. Curr. Drug Abuse Rev. 2008, 1:68-80.
34. Ray G.T., Weisner C.M., Mertens J.R. Relationship between use of psychiatric services and five-year alcohol and drug treatment outcomes. Psychiatr. Serv. 2005, 56:164-171.
35. Riggs P.D., Baker S., Mikulich S.K., Young S.E., Crowley T.J. Depression in substance-dependent delinquents. J. Am. Acad. Child Adolesc. Psychiatry 1995, 34:764-771.
36. Riggs P.D., Mikulich-Gilbertson S.K., Davies R.D., Lohman M., Klein C., Stover S.K. A randomized controlled trial of fluoxetine and cognitive behavioral therapy in adolescents with major depression, behavior problems, and substance use disorders. Arch. Pediatr. Adolesc. Med. 2007, 161:1026-1034.
37. Riggs P.D., Winhusen T., Davies R., Leimberger J., Mikulich-Gilbertson S.K. A randomized controlled trial of OROS-MPH+CBT in adolescents with ADHD and substance use disorders. Symposium Presentation and Symposium Chair; NIDA-Sponsored Symposium at AAAP Annual Meeting 2009.
38. Riggs, P.D., Winhusen, T., Davies, R.D., Leimberger, J.D., Mikulich-Gilbertson, S., Klein, C., Macdonald, M., Lohman, M., Bailey, G.L., Haynes, L., Jaffee, W.B., Hodgkins, C., Whitmore, E., Trello-Rishel, K., Tamm, L., Acosta, M.C., Royer-Malvestuto, C., Subramaniam, G., Holmes, B.W., Kaye, M.E., Vargo, M.A., Woody, G.E., Nunes, E.V., Liu, D. Randomized controlled trial of osmotic-release methylphenidate with CBT in adolescents with ADHD and substance use disorders. J. Am. Acad. Child Adolesc. Psychiatry, in press.
39. Robins L.N. An overview of the diagnostic interview schedule and the composite international diagnostic interview. International Classification in Psychiatry: Unity and Diversity 1988, 205-220. Cambridge University Press, New York. J.E. Mezzich, M. von Cranach (Eds.).
40. Rivers S.M., Greenbaum R.L., Goldberg E. Hospital-based adolescent substance abuse treatment: comorbidity, outcomes and gender. J. Nerv. Ment. Dis. 2001, 189:229-237.
41. Rohde P., Lewinsohn P.M., Seeley J.R. Psychiatric comorbidity with problematic alcohol use in high school students. J. Am. Acad. Child Adolesc. Psychiatry 1996, 35:101-109.
42. Rowe C.L., Liddle H.A., Dakof G.A. Classifying clinically referred adolescent substance abusers by level of externalizing and internalizing symptoms. J. Child Adolesc. Subst. Abuse 2001, 11:41-65.
43. Rowe C.L., Liddle H.A., Greenbaum P.E., Henderson C.E. Impact of psychiatric comorbidity on treatment of adolescent drug abusers. J. Subst. Abuse Treat. 2004, 26:129-140.
44. Shane P.A., Jaiukaitis P., Green R.S. Treatment outcomes among adolescents with substance abuse problems: the relationship between comorbidities and post-treatment substance involvement. Eval. Program Plann. 2003, 26:393-402.
45. Sobell L.C., Sobell M.B. Timeline followback: a technique for assessing self-reported alcohol consumption. Measuring Alcohol Consumption 1992, 207-224. The Humana Press Inc., Rockville, MD. R. Litten, J. Allen (Eds.).
46. Waldron H.B., Slesnick N., Brody J.L., Turner C.W., Peterson T.R. Treatment outcomes for adolescent substance abuse at 4- and 7-month assessments. J. Consult. Clin. Psychol. 2001, 69:802-813.
47. Whitmore E.A., Mikulich S.K., Thompson L.L., Riggs P.D., Aarons G.A., Crowley T.J. Influences on adolescent substance dependence: conduct disorder, depression, attention deficit hyperactivity disorder, and gender. Drug Alcohol Depend. 1997, 47:87-97.
48. Wise B.K., Cuffe S.P., Fischer T. Dual diagnosis and successful participation of adolescents in substance abuse treatment. J. Subst. Abuse Treat. 2001, 21:161-165.